Literature DB >> 7684210

Improved in vitro angiogenesis model by collagen density reduction and the use of type III collagen.

S Kanzawa1, H Endo, N Shioya.   

Abstract

Angiogenesis was examined by a three-dimensional model in vitro, using human umbilical vein endothelial cells (HUVECs) cultured in a collagen gel. An abundant capillary-like network with a lumen structure was identified histologically and shown to have formed at a collagen density of 0.05% or 0.10% instead of 0.15%, for either type I or type III collagen. At the same density, type III collagen induced a capillary-like network with HUVECs at an earlier stage of culture than type I collagen. In a two-dimensional culture, HUVECs were viable and proliferated to a great extent on the culture dish coated with collagen. This was particularly so in the case of type III collagen at lower density (5 ng/cm2). Type III collagen at a sufficiently low density is thus shown useful for studying angiogenesis in vitro. The capillary-like network that formed in the three-dimensional culture appeared somewhat labile, but became stable with the continuous addition of endothelial cell growth supplement and increase in the plating number of HUVECs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684210     DOI: 10.1097/00000637-199303000-00008

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  14 in total

Review 1.  Current methods for assaying angiogenesis in vitro and in vivo.

Authors:  Carolyn A Staton; Stephen M Stribbling; Simon Tazzyman; Russell Hughes; Nicola J Brown; Claire E Lewis
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

Review 2.  In vitro models of angiogenesis.

Authors:  Areck A Ucuzian; Howard P Greisler
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

3.  Procedure for the development of multi-depth circular cross-sectional endothelialized microchannels-on-a-chip.

Authors:  Xiang Li; Samantha Marie Mearns; Manuela Martins-Green; Yuxin Liu
Journal:  J Vis Exp       Date:  2013-10-21       Impact factor: 1.355

Review 4.  A critical analysis of current in vitro and in vivo angiogenesis assays.

Authors:  Carolyn A Staton; Malcolm W R Reed; Nicola J Brown
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

5.  Oxidized low-density lipoprotein alters the effect of matrix stiffness on the formation of endothelial networks and capillary lumens.

Authors:  Madhu S Gundavaram; Tzu Pin Shentu; Gregory B Kowalsky; Suncica Volkov; Dean E Schraufnagel; Irena Levitan
Journal:  Pulm Circ       Date:  2013-12-05       Impact factor: 3.017

6.  Type III collagen modulates fracture callus bone formation and early remodeling.

Authors:  Emily L Miedel; Becky K Brisson; Todd Hamilton; Hadley Gleason; Gary P Swain; Luke Lopas; Derek Dopkin; Joseph E Perosky; Kenneth M Kozloff; Kurt D Hankenson; Susan W Volk
Journal:  J Orthop Res       Date:  2015-03-08       Impact factor: 3.494

7.  Microelastic properties of lung cell-derived extracellular matrix.

Authors:  Patricia A Soucy; Jeffery Werbin; William Heinz; Jan H Hoh; Lewis H Romer
Journal:  Acta Biomater       Date:  2010-07-23       Impact factor: 8.947

8.  Endothelial actin and cell stiffness is modulated by substrate stiffness in 2D and 3D.

Authors:  Fitzroy J Byfield; Rashmeet K Reen; Tzu-Pin Shentu; Irena Levitan; Keith J Gooch
Journal:  J Biomech       Date:  2009-04-07       Impact factor: 2.712

9.  Enhanced proliferation of human umbilical vein endothelial cells and differentiation of 3T3-L1 adipocytes in coculture.

Authors:  Ning Lai; Arul Jayaraman; Kyongbum Lee
Journal:  Tissue Eng Part A       Date:  2009-05       Impact factor: 3.845

Review 10.  Role of the retinal vascular endothelial cell in ocular disease.

Authors:  Arpita S Bharadwaj; Binoy Appukuttan; Phillip A Wilmarth; Yuzhen Pan; Andrew J Stempel; Timothy J Chipps; Eric E Benedetti; David O Zamora; Dongseok Choi; Larry L David; Justine R Smith
Journal:  Prog Retin Eye Res       Date:  2012-09-11       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.